SHA:600535 Revenue

Tasly Pharmaceutical Group had revenue of 2.02B CNY in the quarter ending September 30, 2025, a decrease of -3.27%. This brings the company's revenue in the last twelve months to 8.35B, down -2.56% year-over-year. In the year 2024, Tasly Pharmaceutical Group had annual revenue of 8.50B, down -2.03%.

Revenue (ttm)

8.35B

Revenue Growth

-2.56%

P/S Ratio

2.75

Revenue / Employee

761.66K

Employees

10,958

Market Cap

22.93B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.50B	-175.87M	-2.03%
Dec 31, 2023	8.67B	36.58M	0.42%
Dec 31, 2022	8.64B	685.47M	8.62%
Dec 31, 2021	7.95B	-5.62B	-41.43%
Dec 31, 2020	13.58B	-5.42B	-28.54%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	30.98B
WuXi AppTec	43.88B
Shenzhen Mindray Bio-Medical Electronics	33.07B
Sichuan Biokin Pharmaceutical	2.23B
Shanghai United Imaging Healthcare	12.20B
Aier Eye Hospital Group	22.17B
Zhangzhou Pientzehuang Pharmaceutical.,	9.78B
Yunnan Baiyao Group Co.,Ltd	40.77B

Revenue Rankings